ESMO is the leading European professional organisation for medical oncology. Comprising more than 25,000 oncology professionals from over 150 countries, we are the society of reference for oncology education and information. We are committed to supporting our members to develop and advance in a fast-evolving professional environment.
Founded in 1975, ESMO has European roots with a global reach: we welcome oncology professionals from around the world. We are a home for all oncology stakeholders, connecting professionals with diverse expertise and experience, and speaking with one voice for our discipline. Our education and information resources support an integrated multi-professional approach to cancer care, from a medical oncology perspective.
We seek to erase boundaries in cancer care, whether between countries or specialities and pursue our mission across oncology, worldwide.
2019 Impact Factor
ESMO20 YO for YO: Highlights on metastatic NSCLC-Keynote 024 update
In this podcast, Dr Elene Mariamidze (a member of the ESMO Young Oncologists Committee) interviews Dr Laura Mezquita (Thoracic Oncology Group) regarding novelties presented on ESMO 2020 in the field of metastatic NSCLC.
Further podcasts can be found here.
Seeking New Editor In Chief
Under the leadership of its inaugural Editor-in-Chief, Professor Christoph Zielinski, the journal has grown in size and stature, posting a first impact factor of 5.329 in 2020. At the end of 2021 ESMO Professor Zielinski will step down from this role, and ESMO is now seeking a new Editor-in-Chief to guide the Journal through the next phase of its development. For further details see here.